179 related articles for article (PubMed ID: 9406655)
21. Complexities of glucuronidation affecting in vitro in vivo extrapolation.
Lin JH; Wong BK
Curr Drug Metab; 2002 Dec; 3(6):623-46. PubMed ID: 12369890
[TBL] [Abstract][Full Text] [Related]
22. Revisiting the Latency of Uridine Diphosphate-Glucuronosyltransferases (UGTs)-How Does the Endoplasmic Reticulum Membrane Influence Their Function?
Liu Y; Coughtrie MWH
Pharmaceutics; 2017 Aug; 9(3):. PubMed ID: 28867809
[TBL] [Abstract][Full Text] [Related]
23. [UDP-glucuronyltransferases, proteins of endoplasmic reticulum--structure and mechanism of action].
Fedejko B; Mazerska Z
Postepy Biochem; 2011; 57(1):41-8. PubMed ID: 21735819
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of the monkey UGT2B30 gene that encodes a uridine diphosphate-glucuronosyltransferase enzyme active on mineralocorticoid, glucocorticoid, androgen and oestrogen hormones.
Girard C; Barbier O; Turgeon D; Bélanger A
Biochem J; 2002 Jul; 365(Pt 1):213-22. PubMed ID: 12071853
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.
Miley MJ; Zielinska AK; Keenan JE; Bratton SM; Radominska-Pandya A; Redinbo MR
J Mol Biol; 2007 Jun; 369(2):498-511. PubMed ID: 17442341
[TBL] [Abstract][Full Text] [Related]
26. Characterization of UDP-glucuronic acid transport in rat liver microsomal vesicles with photoaffinity analogs.
Radominska A; Berg C; Treat S; Little JM; Lester R; Gollan JL; Drake RR
Biochim Biophys Acta; 1994 Oct; 1195(1):63-70. PubMed ID: 7918567
[TBL] [Abstract][Full Text] [Related]
27. Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts.
Vienneau DS; DeBoni U; Wells PG
Cancer Res; 1995 Mar; 55(5):1045-51. PubMed ID: 7866987
[TBL] [Abstract][Full Text] [Related]
28. Functional Interaction between Cytochrome P450 and UDP-Glucuronosyltransferase on the Endoplasmic Reticulum Membrane: One of Post-translational Factors Which Possibly Contributes to Their Inter-Individual Differences.
Miyauchi Y; Takechi S; Ishii Y
Biol Pharm Bull; 2021; 44(11):1635-1644. PubMed ID: 34719641
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of UDP-GlcUA transport in endoplasmic reticulum and in Golgi membranes.
Bossuyt X; Blanckaert N
J Hepatol; 2001 Feb; 34(2):210-4. PubMed ID: 11281548
[TBL] [Abstract][Full Text] [Related]
30. Glucuronidation of haloperidol by rat liver microsomes: involvement of family 2 UDP-glucuronosyltransferases.
Narayanan R; LeDuc B; Williams DA
Life Sci; 2004 Apr; 74(20):2527-39. PubMed ID: 15010263
[TBL] [Abstract][Full Text] [Related]
31. Modulation of benzo[a]pyrene bioactivation by glucuronidation in lymphocytes and hepatic microsomes from rats with a hereditary deficiency in bilirubin UDP-glucuronosyltransferase.
Hu Z; Wells PG
Toxicol Appl Pharmacol; 1994 Aug; 127(2):306-13. PubMed ID: 8048075
[TBL] [Abstract][Full Text] [Related]
32. Regulation of bilirubin glucuronide synthesis in primate (Macaca fascicularis) liver. Kinetic analysis of microsomal bilirubin uridine diphosphate glucuronyltransferase.
Hauser SC; Ziurys JC; Gollan JL
Gastroenterology; 1986 Aug; 91(2):287-96. PubMed ID: 3087808
[TBL] [Abstract][Full Text] [Related]
33. Optimization of Experimental Conditions of Automated Glucuronidation Assays in Human Liver Microsomes Using a Cocktail Approach and Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry.
Badée J; Qiu N; Parrott N; Collier AC; Schmidt S; Fowler S
Drug Metab Dispos; 2019 Feb; 47(2):124-134. PubMed ID: 30478159
[TBL] [Abstract][Full Text] [Related]
34. Phylogenetic and mutational analyses reveal key residues for UDP-glucuronic acid binding and activity of beta1,3-glucuronosyltransferase I (GlcAT-I).
Fondeur-Gelinotte M; Lattard V; Oriol R; Mollicone R; Jacquinet JC; Mulliert G; Gulberti S; Netter P; Magdalou J; Ouzzine M; Fournel-Gigleux S
Protein Sci; 2006 Jul; 15(7):1667-78. PubMed ID: 16815917
[TBL] [Abstract][Full Text] [Related]
35. Drug glucuronidation by human renal UDP-glucuronosyltransferases.
McGurk KA; Brierley CH; Burchell B
Biochem Pharmacol; 1998 Apr; 55(7):1005-12. PubMed ID: 9605424
[TBL] [Abstract][Full Text] [Related]
36. The importance of local chemical structure for chemical metabolism by human uridine 5'-diphosphate-glucuronosyltransferase.
Sorich MJ; McKinnon RA; Miners JO; Smith PA
J Chem Inf Model; 2006; 46(6):2692-7. PubMed ID: 17125209
[TBL] [Abstract][Full Text] [Related]
37. A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years.
Radominska-Pandya A; Bratton S; Little JM
Curr Drug Metab; 2005 Apr; 6(2):141-60. PubMed ID: 15853765
[TBL] [Abstract][Full Text] [Related]
38. Uridine diphosphate sugar-selective conjugation of an aldose reductase inhibitor (AS-3201) by UDP-glucuronosyltransferase 2B subfamily in human liver microsomes.
Toide K; Terauchi Y; Fujii T; Yamazaki H; Kamataki T
Biochem Pharmacol; 2004 Apr; 67(7):1269-78. PubMed ID: 15013842
[TBL] [Abstract][Full Text] [Related]
39. Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3-hydroxydesloratadine.
Ghosal A; Yuan Y; Hapangama N; Su AD; Alvarez N; Chowdhury SK; Alton KB; Patrick JE; Zbaida S
Biopharm Drug Dispos; 2004 Sep; 25(6):243-52. PubMed ID: 15334623
[TBL] [Abstract][Full Text] [Related]
40. A molecular model of the human UDP-glucuronosyltransferase 1A1, its membrane orientation, and the interactions between different parts of the enzyme.
Laakkonen L; Finel M
Mol Pharmacol; 2010 Jun; 77(6):931-9. PubMed ID: 20215562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
